Senior Director Commercial Strategy, Genentech
Kevin Noble is the Senior Director of Commercial Strategy – In this role, he focuses on developing futurists who map market uncertainties then courageously explore, evaluate and experiment to catalyze action to solve key healthcare challenges. His team’s current portfolio includes identification of next generation, early disease diagnosis (Alzheimer’s, cancer and rare respiratory diseases); solutions to end cervical cancer; extending the acute stroke window of opportunity; and opportunities for machine learning/artificial intelligence to generate unique healthcare insights.
Kevin is accountable to reach beyond boundaries to connect internal and external experts who share a passion in science, data and technology to shape new, differentiated offerings that impact healthcare delivery and measurably improve patient outcomes. He established the Genentech Corporate Founder relationship with Singularity University and has been an active sponsor of Exponential Medicine, Global Solutions Program and the Singularity Summit.
Kevin is an alumni of the University of Illinois (BA) and Northwestern University (MS). He has studied health economics and outcomes research at the University of York (England). He is also an alumni of Singularity University’s Executive Program, FutureMed and Exponential Medicine programs.
Away from the office, he is an accomplished landscape and wildlife photographer whose favorite subject is the grizzly bear. With his family, he enjoys exploring life and encouraging his adult children to think big in STEM innovation.
View More Exponential Medicine Faculty
Exponential Medicine brings together top experts to inform medical leaders how technology is impacting business. View the full list of 2016 faculty: